4.7 Article

The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Therapeutic Effect of Costunolide in Autoimmune Hepatitis: Network Pharmacology and Experimental Validation

Zheng Huang et al.

Summary: This study demonstrates that costunolide has a significant therapeutic effect in autoimmune hepatitis (AIH) by suppressing the activation of the PI3K-AKT pathway and inhibiting the phosphorylation of SRC and IGF1R. The findings reveal the potential role of SRC and IGF1R in AIH and contribute to the development of novel drugs for AIH and other autoimmune diseases.

PHARMACEUTICALS (2023)

Article Integrative & Complementary Medicine

Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease

Juan Hao et al.

Summary: This study aimed to investigate the pharmacodynamic effects of costunolide (COS) from Saussurea lappa on cholestatic liver disease. Two experiments revealed that COS administration improved the symptoms of cholestatic liver disease, including ductular reaction, hepatoperiductal fibrosis, and inflammatory response. The hepatoprotective effects of COS were mainly mediated by its regulation of bile acid metabolism and inflammatory response.

JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2023)

Article Medicine, General & Internal

Pharmacological Mechanism of Aucklandiae Radix against Gastric Ulcer Based on Network Pharmacology and In Vivo Experiment

Lan Feng et al.

Summary: This study combined network pharmacology and animal experimentation to explore the potential active components, core targets, and mechanisms of Aucklandiae Radix in treating gastric ulcer. The results showed that Aucklandiae Radix contains eight potential active components and 331 predicted targets, with 37 common targets associated with gastric ulcer. The key components identified were stigmasterol, mairin, sitosterol, and dehydrocostus lactone, and the core targets were AKT1, PTGS2, IL1B, CASP3, and CASP8. Aucklandiae Radix exhibited therapeutic effects against gastric ulcer through antibacterial, anti-inflammatory, prostaglandin receptor response, and apoptosis-related pathways.

MEDICINA-LITHUANIA (2023)

Article Cell Biology

ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway

Lin Cai et al.

Summary: This study found that ACT001 can alleviate neurodegeneration after TBI by reducing the activation of microglia cells. ACT001 can inhibit the production of pro-inflammatory cytokines induced by LPS, improve cellular apoptosis and tube formation, and its mechanism of action is related to the AKT/NF kappa B/NLRP3 pathway.

CELL COMMUNICATION AND SIGNALING (2022)

Review Neurosciences

Hepatic stellate cells in physiology and pathology

Dakota R. Kamm et al.

Summary: Hepatic stellate cells (HSCs) play critical roles in the normal liver and in response to injury. They are activated during liver injury and produce extracellular matrix in liver fibrosis. In the absence of injury, HSCs are in a quiescent state and store retinoids or vitamin A-containing metabolites. They also enhance the inflammatory response and express growth factors crucial for liver development and regeneration. Recent studies have identified diverse phenotypic alterations and unique subpopulations of HSCs.

JOURNAL OF PHYSIOLOGY-LONDON (2022)

Review Immunology

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis

Can Gan et al.

Summary: This review summarizes the activation and function of inflammasome complexes and discusses the association between inflammasomes, pyroptosis, and liver fibrosis. Unlike other reviews, the author focuses on the effect of inflammasome activation in various liver cells during the development of liver fibrosis and highlights the latest progress of pharmacological intervention in inflammasome-mediated liver fibrosis.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling

Chenxu Ge et al.

Summary: In this study, Mul administration was found to significantly ameliorate liver injury and dysfunction induced by CCl4 in mice. The underlying mechanisms involve the suppression of TGF-beta 1/SMAD2/3 signaling pathway and NF-kappa B signaling, as well as the activation of TRIM31 and Nrf2 pathways. These findings provide a novel therapeutic strategy for hepatic fibrosis treatment.

REDOX BIOLOGY (2022)

Article Cell Biology

Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells

Michal Safran et al.

Summary: Liver fibrosis (LF) is a major global health issue, and this study investigated the role of hepatocyte-secreted extracellular vesicles (EVs) in liver fibrosis. The study found that EVs regulate the differentiation of hepatic stellate cells (HSCs) and that miR-423-5p, carried by EVs, is involved in HSCs differentiation and fibrosis development.
Article Cell Biology

Genetic Characterization of Rat Hepatic Stellate Cell Line HSC-T6 for In Vitro Cell Line Authentication

Indrajit Nanda et al.

Summary: Immortalized hepatic stellate cells (HSCs) are valuable tools for liver biology research, but their use has some drawbacks, such as genetic drift and cell misidentification. This study characterizes the genetic features of the rat HSC line HSC-T6 and proposes cell line authentication.
Article Nanoscience & Nanotechnology

Silica Nanoparticles Cause Activation of NLRP3 Inflammasome in-vitro Model-Using Microglia

Shanshan Hou et al.

Summary: The study found that SiNPs can induce inflammatory response and ferroptosis in neuroimmune cells, mediated by the activation of NLRP3 inflammasomes. Further research revealed that silencing the NLRP3 gene can alleviate these damages.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Article Biochemistry & Molecular Biology

Evaluation of the Effects of Microgravity on Activated Primary Human Hepatic Stellate Cells

Koichi Fujisawa et al.

Summary: Research has been conducted to develop new medical treatments by simulating environments existing in space, such as zero-gravity. In this study, cell proliferation and gene expression of activated primary human hepatic stellate cells (HHSteCs) under simulated microgravity (SMG) were evaluated. The findings showed slower cell proliferation under SMG conditions, as well as changes in gene expression and oxidative stress. Upstream regulators were activated and cell-permeable inhibitors were inhibited, and cytoskeletal changes were observed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Nutrition & Dietetics

Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway

Xiujing Dou et al.

Summary: Thymol has been shown to protect the liver from LPS-induced injury by inhibiting the activation of NLRP3 inflammasome. It alleviates inflammatory cell infiltration and structural damage in the liver, and reduces the levels of liver damage indicators. Additionally, thymol regulates the activity of lactate dehydrogenase and the expression of inflammatory cytokines and apoptosis-related genes, thereby exerting a protective effect on the liver.

NUTRIENTS (2022)

Article Cell & Tissue Engineering

Notch-activated mesenchymal stromal/stem cells enhance the protective effect against acetaminophen-induced acute liver injury by activating AMPK/SIRT1 pathway

Mengxue Yu et al.

Summary: This study found that activation of Notch2 is necessary for MSCs to alleviate acute liver injury. Notch activation through the AMPK/SIRT1 signaling pathway reduces the activation of NLRP3 inflammasome, thus greatly enhancing the anti-inflammatory activity and therapeutic effects of MSCs.

STEM CELL RESEARCH & THERAPY (2022)

Article Biochemistry & Molecular Biology

Cold Stress Induced Liver Injury of Mice through Activated NLRP3/Caspase-1/GSDMD Pyroptosis Signaling Pathway

Yuanyuan Liu et al.

Summary: This study investigates the effects of chronic cold exposure on liver function, apoptosis, oxidative stress, and inflammation in mice. The results suggest that cold stress can lead to liver injury and activate apoptosis, oxidative stress, and pyroptosis. The findings provide new insights into the underlying mechanisms of the cold stress response.

BIOMOLECULES (2022)

Article Chemistry, Medicinal

Phloridzin Reveals New Treatment Strategies for Liver Fibrosis

Yahong Shi et al.

Summary: Liver fibrosis is a pressing public health issue, and phloridzin has been found to effectively treat liver fibrosis, potentially through mechanisms involving cell ferroptosis, carbon metabolism, and related biomechanical changes.

PHARMACEUTICALS (2022)

Article Food Science & Technology

Protective Effect of SeMet on Liver Injury Induced by Ochratoxin A in Rabbits

Ziqiang Zhang et al.

Summary: The study found that selenomethionine has a protective effect on liver injury induced by Ochratoxin A (OTA), improving pathological damage and oxidative stress caused by OTA poisoning in rabbits.

TOXINS (2022)

Article Cell Biology

Multiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis

Jaejun Lee et al.

Summary: This study utilized multiplexed digital spatial protein profiling to develop a unique protein signature predicting advanced liver fibrosis. Through single-cell RNA sequencing analysis and protein-based multiplexed profiling, the study revealed the phenotypic differences of portal MPs between livers with early- or late-stage fibrosis.
Article Pharmacology & Pharmacy

Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis

Asmaa A. Ashour et al.

Summary: Liver fibrosis is a life-threatening disorder with no approved treatment. Luteolin, a plant flavonoid, has potential therapeutic effects in liver fibrosis. However, its poor solubility and metabolism hinder its clinical use. In this study, bone marrow MSCs-derived exosomes were developed as a promising nanocarrier for effective treatment of liver fibrosis.

DRUG DELIVERY (2022)

Article Gastroenterology & Hepatology

Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

Susanne Gaul et al.

Summary: The study found that hepatocyte pyroptosis, caused by NLRP3 inflammasome activation, leads to the release of inflammasome proteins and exacerbates fibrogenesis. Inhibition of caspase-1 and gasdermin D activation can prevent pyroptosis. The released inflammasomes are taken up by hepatic stellate cells, promoting inflammation and fibrosis. These findings suggest a novel mechanism for liver injury and potential therapeutic targets for chronic liver diseases.

JOURNAL OF HEPATOLOGY (2021)

Article Biology

Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome

Hyun Young Kim et al.

Summary: This study conducted in mouse models of liver fibrosis revealed that auranofin exerts its therapeutic effects by inhibiting the NLRP3 inflammasome via the system Xc pathway in bone marrow-derived macrophages and kupffer cells. This inhibition was shown to reduce migration of hepatic stellate cells, providing a potential new approach for treating liver fibrosis.

COMMUNICATIONS BIOLOGY (2021)

Article Cell Biology

miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting β-catenin/SOX9/TGF-β1 pathway

Qi Wang et al.

Summary: The study highlighted the regulatory role of lncRNA NEAT1 and miR-139-5p in liver fibrosis progression, with NEAT1 promoting HSCs activation by sponging miR-139-5p. The overexpression of miR-139-5p or knockdown of NEAT1 alleviated liver fibrosis in vivo by targeting the beta-catenin/SOX9/TGF-beta 1 pathway.

CELL DEATH DISCOVERY (2021)

Article Gastroenterology & Hepatology

Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis

Eun Hee Koh et al.

Summary: The study revealed the significant role of free cholesterol and sphingomyelin synthases (SMS) in the pathogenesis of NASH, inducing hepatocyte pyroptosis and inflammasome activation. This novel pathway involving DAG-PKCd-NLRC4 axis mediated by SMS1 could potentially serve as a therapeutic target for NASH.
Article Cell Biology

Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis

Chan Mo et al.

Summary: The study demonstrates that IDO1 affects the recruitment of immune cells by inhibiting DCs maturation and subsequent T cell proliferation, exacerbating the progression of liver fibrosis. Targeting IDO1 to ameliorate immune responses in the hepatic and splenic microenvironment may be essential for therapeutic effects on liver fibrosis.

CELL DEATH & DISEASE (2021)

Article Biochemistry & Molecular Biology

MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs

Shuang Ge et al.

Summary: Deficiency of MyD88 in myeloid cells attenuates liver fibrosis and reduces inflammatory cell infiltration, possibly through inhibiting the secretion of CXCL2. Targeting CXCL2 using CXCR2 inhibitors can also reduce liver fibrosis. MyD88 may be a potential target for the prevention and treatment of liver fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Aquaporin 9 Represents a Novel Target of Chronic Liver Injury That May Antagonize Its Progression by Reducing Lipotoxicity

Quancheng Cheng et al.

Summary: Aquaporin 9 was identified as a potential therapeutic target for early chronic liver injury in this study, with gene knockout alleviating downstream inflammation, oxidative stress, apoptosis, and pyroptosis by reducing hepatic lipotoxicity.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Biotechnology & Applied Microbiology

Gastrodin attenuates perfluorooctanoic acid-induced liver injury by regulating gut microbiota composition in mice

Shumin Ma et al.

Summary: Gastrodin can effectively alleviate PFOA-induced liver injury by regulating gut microbiota composition. It reduces oxidative stress, increases the relative abundance of beneficial bacteria, and increases the level of short-chain fatty acids.

BIOENGINEERED (2021)

Article Medicine, Research & Experimental

NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients

Chao Zhang et al.

Summary: Chronic HIV-1 infection leads to CD4(+) T cell loss, with distinct mechanisms affecting pyroptotic and apoptotic CD4(+) T cells. Pyroptosis is closely associated with inflammation and driven by NLRP3 inflammasome activation, while apoptosis is more related to T cell activation status.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Cell Biology

NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1

Zheng Xu et al.

Summary: The study revealed that activation of the NLRP3 inflammasome played a vital role in promoting the malignant progression of prostate cancer via the activation of caspase-1, providing potential targets for clinical diagnosis and treatment.

CELL DEATH DISCOVERY (2021)

Article Medicine, Research & Experimental

Monocytes promote pyroptosis of endothelial cells during lung ischemia-reperfusion via IL-1R/NF-?B/NLRP3 signaling

Peng Zhou et al.

Summary: This study reveals a potential mechanism in which monocytes induce HPMEC pyroptosis through the IL-1β/IL-1R/NF-κB/NLRP3 pathway, playing a crucial role in the development of transplant-associated ischemia-reperfusion injury.

LIFE SCIENCES (2021)

Article Multidisciplinary Sciences

The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1

Yue Xi et al.

Summary: The study demonstrates that GLRX reverses PSSG by liberating GSH, inhibiting activation of hepatic stellate cells and liver fibrosis. GLRX depletion exacerbates liver fibrosis, while overexpression of GLRX inhibits PSSG and liver fibrosis development.

SCIENCE ADVANCES (2021)

Article Chemistry, Medicinal

Costunolide Loaded in pH-Responsive Mesoporous Silica Nanoparticles for Increased Stability and an Enhanced Anti-Fibrotic Effect

Xia Niu et al.

Summary: The use of pH-responsive mesoporous silica nanoparticles (MSNs) coated with methacrylic acid copolymer (MAC) as a carrier for Costunolide (COS) showed promising results in improving the stability, dissolution rate, and efficacy of COS in treating liver fibrosis. This novel approach effectively inhibited hepatic fibrogenesis and offers great potential for anti-liver fibrosis treatment.

PHARMACEUTICALS (2021)

Review Medicine, General & Internal

Macrophage Polarization and Liver Ischemia-Reperfusion Injury

Hai Wang et al.

Summary: Liver ischemia-reperfusion injury is a hot research topic in recent years, related to liver surgery and transplantation. Macrophages play a crucial role in triggering and maintaining liver IRI.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Article Biotechnology & Applied Microbiology

MicroRNA 223 3p Negatively Regulates the NLRP3 Inflammasome in Acute and Chronic Liver Injury

Carolina Jimenez Calvente et al.

MOLECULAR THERAPY (2020)

Article Pharmacology & Pharmacy

Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation

Mao-xu Ge et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Review Medicine, Research & Experimental

Mechanisms of liver fibrosis and its role in liver cancer

Debanjan Dhar et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2020)

Article Gastroenterology & Hepatology

Tamarix chinensis Lour inhibits chronic ethanol-induced liver injury in mice

Zhi-Dan Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Review Cell Biology

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

Natascha Roehlen et al.

Article Cell Biology

GDF11 induces mild hepatic fibrosis independent of metabolic health

Jan Frohlich et al.

AGING-US (2020)

Article Gastroenterology & Hepatology

GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a beta 1-Integrin Pathway

Usman Yaqoob et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2

Dujing Ban et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)

Article Medicine, Research & Experimental

Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223

Carolina Jimenez Calvente et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Gastroenterology & Hepatology

Crosstalk network among multiple inflammatory mediators in liver fibrosis

Han-Jing Zhangdi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice

Alexander Wree et al.

HEPATOLOGY (2018)

Article Integrative & Complementary Medicine

Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats

Huimin Liu et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)

Article Biochemistry & Molecular Biology

Trehalose supplementation reduces hepatic endoplasmic reticulum stress and inflammatory signaling in old mice

Michael J. Pagliassotti et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)

Review Gastroenterology & Hepatology

Inflammasomes in Liver Fibrosis

Fernando Alegre et al.

SEMINARS IN LIVER DISEASE (2017)

Article Toxicology

Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis

Shu Dong et al.

JOURNAL OF TOXICOLOGICAL SCIENCES (2016)

Article Pharmacology & Pharmacy

NLRP3 inflammasome and its inhibitors: a review

Bo-Zong Shao et al.

FRONTIERS IN PHARMACOLOGY (2015)